A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 2 / Phase 3 · Enrolling participants
Planned enrollment: 1,092 participants
Study ages: 18 Years and older
Recruiting sites listed in: Argentina, Australia, Belgium, Brazil, Canada and 23 more countries/territories (see details)
No results-posting date in this record
Read trial record and resultsChecked Nov 17, 2026